Limits...
Efficacy of platelet-rich plasma in treatment of androgenic alopecia.

Singhal P, Agarwal S, Dhot PS, Sayal SK - Asian J Transfus Sci (2015 Jul-Dec)

Bottom Line: The growth factors in activated autologous PRP induce the proliferation of dermal papilla cells.Ten patients were given autologous PRP injections on the affected area of alopecia over a period of 3 months at interval of 2-3 weeks and results were assessed.Three months after the treatment, the patients presented clinical improvement in the hair counts, hair thickness, hair root strength, and overall alopecia.

View Article: PubMed Central - PubMed

Affiliation: Department of Pathology, Santosh Medical College, Ghaziabad, Uttar Pradesh, India.

ABSTRACT

Background: Platelet-rich plasma (PRP) has shown remarkable beneficial effects without any major adverse reactions in the treatment of androgenic alopecia. The growth factors in activated autologous PRP induce the proliferation of dermal papilla cells.

Objectives: The objective was to investigate the clinical efficacy of PRP in treatment of androgenic alopecia.

Materials and methods: Ten patients were given autologous PRP injections on the affected area of alopecia over a period of 3 months at interval of 2-3 weeks and results were assessed.

Results: Three months after the treatment, the patients presented clinical improvement in the hair counts, hair thickness, hair root strength, and overall alopecia.

Conclusion: PRP appears to be a cheap, effective, and promising therapy for androgenic alopecia with no major adverse effects.

No MeSH data available.


Related in: MedlinePlus

Before
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4562137&req=5

Figure 1: Before

Mentions: Hair growth was seen in six patients after 7 days and in four patients after 15 days. By the end of 3 months, all ten patients had good hair growth [Figures 1-4]. Three patients complained of a mild headache after the initial procedure which was alleviated after paracetamol 500 mg. None of the patients had any inflammation or infection.


Efficacy of platelet-rich plasma in treatment of androgenic alopecia.

Singhal P, Agarwal S, Dhot PS, Sayal SK - Asian J Transfus Sci (2015 Jul-Dec)

Before
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4562137&req=5

Figure 1: Before
Mentions: Hair growth was seen in six patients after 7 days and in four patients after 15 days. By the end of 3 months, all ten patients had good hair growth [Figures 1-4]. Three patients complained of a mild headache after the initial procedure which was alleviated after paracetamol 500 mg. None of the patients had any inflammation or infection.

Bottom Line: The growth factors in activated autologous PRP induce the proliferation of dermal papilla cells.Ten patients were given autologous PRP injections on the affected area of alopecia over a period of 3 months at interval of 2-3 weeks and results were assessed.Three months after the treatment, the patients presented clinical improvement in the hair counts, hair thickness, hair root strength, and overall alopecia.

View Article: PubMed Central - PubMed

Affiliation: Department of Pathology, Santosh Medical College, Ghaziabad, Uttar Pradesh, India.

ABSTRACT

Background: Platelet-rich plasma (PRP) has shown remarkable beneficial effects without any major adverse reactions in the treatment of androgenic alopecia. The growth factors in activated autologous PRP induce the proliferation of dermal papilla cells.

Objectives: The objective was to investigate the clinical efficacy of PRP in treatment of androgenic alopecia.

Materials and methods: Ten patients were given autologous PRP injections on the affected area of alopecia over a period of 3 months at interval of 2-3 weeks and results were assessed.

Results: Three months after the treatment, the patients presented clinical improvement in the hair counts, hair thickness, hair root strength, and overall alopecia.

Conclusion: PRP appears to be a cheap, effective, and promising therapy for androgenic alopecia with no major adverse effects.

No MeSH data available.


Related in: MedlinePlus